Karen L. Zaderej - 16 May 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
16 May 2025
Net transactions value
+$59,000
Form type
4
Filing time
19 May 2025, 16:06:14 UTC
Previous filing
15 May 2025
Next filing
11 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zaderej Karen L. Director C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, WATERTOWN /s/ Ron Honig, Attorney-in-Fact 19 May 2025 0001530968

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Purchase $29,050 +5,000 +19% $5.81 31,500 16 May 2025 Direct
transaction EYPT Common Stock Purchase $29,950 +5,000 +16% $5.99 36,500 19 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.